Environmental particulate matter has long been scrutinized for its pulmonary effects, yet its capacity to perturb systemic metabolic homeostasis remains an area of active mechanistic exploration. The liver, functioning as the central hub for glucose and lipid processing, presents a particularly vulnerable target for airborne pollutants that translocate beyond the respiratory tract. A recent study published in Journal of Environmental Sciences advances this understanding by establishing a real-ambient PM exposure paradigm and dissecting the macrophage-intrinsic mechanisms that propagate metabolic stress signals to hepatocytes.

The investigators employed an individually ventilated cage system installed in Shijiazhuang to deliver authentic ambient PM to male C57BL/6 mice over a 15-week period. This approach avoids the limitations of concentrated or artificially generated particles, instead capturing the genuine physicochemical complexity of urban aerosols. Hepatic histology revealed disorganized hepatocyte architecture, cytoplasmic rarefaction, and lipid accumulation in PM-exposed animals. Periodic acid-Schiff staining further demonstrated markedly depleted glycogen reserves, indicating compromised glucose storage capacity at the tissue level.

At the molecular level, the insulin signaling cascade showed significant perturbation. Western blot analysis of liver lysates revealed elevated inhibitory phosphorylation of IRS1 at serine 307 alongside diminished activating phosphorylation of Akt at serine 473. Quantitative PCR expanded this profile by showing suppressed expression of glycogen synthesis genes—Gys1 and Gys2—while glycolytic transcripts such as Pklr and Eno1 were upregulated. De novo lipogenesis markers also trended upward. Collectively, these data establish that chronic PM exposure remodels hepatic glucose handling at both the signaling and transcriptional tiers.

A critical observation was the pronounced infiltration of F4/80-positive macrophages exhibiting a proinflammatory CD86-high phenotype within the liver parenchyma. Given that hepatic sinusoidal blood flow is relatively sluggish, macrophages residing in this niche have extended opportunity to encounter and internalize circulating particulates. Previous reports have documented PM particles smaller than 2 µm within Kupffer cells, and the current study leverages this anatomical reality to probe whether macrophage activation serves as the mechanistic bridge between inhalation exposure and hepatic metabolic dysfunction.

To interrogate this possibility, the authors constructed a Transwell co-culture system pairing PM-challenged macrophages with primary hepatocytes. J774A.1 cells and primary hepatic macrophages were seeded in the upper compartment and exposed to PM for 72 hours, while hepatocytes occupied the lower chamber separated by a 0.4 µm porous membrane. This configuration permits soluble factor exchange without direct cell-to-cell contact. Hepatocytes co-cultured with PM-exposed macrophages recapitulated the in vivo phenotype: IRS1-Akt signaling was suppressed, glycogen synthesis genes were downregulated, and glycolytic plus lipogenic transcripts were elevated. Notably, direct PM exposure of hepatocytes in monoculture failed to produce comparable metabolic disruption, underscoring that macrophages are not merely incidental bystanders but active signal transducers in this context.

The secreted factor driving this intercellular communication was identified as IL-1β. PM-exposed macrophages exhibited robust NLRP3 inflammasome activation, evidenced by punctate NLRP3 immunofluorescence, elevated ASC expression, and increased caspase-1 p20 cleavage. ELISA quantification confirmed substantial IL-1β release into the co-culture medium. When macrophages were pre-incubated with MCC950—a selective NLRP3 inflammasome inhibitor—prior to PM exposure, IL-1β secretion was abolished, and hepatocytes in the lower chamber retained normal insulin signaling and glucose metabolic gene expression. Parallel experiments using an IL-1β neutralizing antibody produced comparable attenuation of the phenotype. These inhibition studies functionally validate the NLRP3-IL-1β axis as the causal mediator rather than a correlative marker.

Upstream of NLRP3 assembly, the investigators identified lysosomal damage as the triggering event. Transmission electron microscopy of PM-exposed J774A.1 cells revealed intracellular particles smaller than 2 µm, numerous swollen secondary lysosomes, and instances of lysosomal rupture. Western blotting showed decreased LAMP1 and LAMP2 alongside increased cathepsin B, consistent with compromised lysosomal membrane integrity and content leakage. Pharmacological blockade of cathepsin B using CA-074 significantly attenuated NLRP3, ASC, and caspase-1 p20 expression, positioning cathepsin B release as a requisite step in the activation sequence. Additionally, PM exposure increased LC3-II and p62 levels, indicating autophagosome formation coupled with impaired autophagosome-lysosome fusion—a blockage that likely contributes to lysosomal stress and subsequent inflammasome priming.

To translate these in vitro findings into an intact physiological setting, the team generated a liver-specific Nlrp3 knockdown model using adeno-associated virus-mediated shRNA delivery. Following tail vein injection and a 21-day expression period, hepatic NLRP3 protein was effectively suppressed. These mice, along with AAV-null controls, received weekly intratracheal PM instillations for four weeks. Histological and molecular analyses revealed that hepatic Nlrp3 silencing attenuated PM-induced glycogen depletion, restored normal hepatocyte morphology, and normalized glucose metabolic gene expression patterns.

A pivotal functional readout in this in vivo validation was the insulin tolerance test. After a four-hour fast, mice received an intraperitoneal injection of recombinant insulin sourced from AbMole (United States) at 0.75 U/kg. Blood glucose was tracked over a two-hour window. PM-exposed control animals displayed markedly blunted glucose clearance, consistent with compromised peripheral insulin responsiveness. In striking contrast, AAV-shNLRP3 mice exposed to identical PM levels exhibited glucose decay kinetics indistinguishable from filtered-air controls. These ITT results align precisely with the molecular restoration of IRS1-Akt phosphorylation observed in the knockdown livers, reinforcing that NLRP3 expression in hepatic tissue is rate-limiting for the metabolic phenotype. The AbMole insulin preparation provided a standardized, reproducible hormonal challenge that enabled quantitative comparison of insulin responsiveness across genotypes and exposure conditions.

Transcriptome-level insights further contextualized these findings. Differential expression analysis comparing PM-exposed and control livers identified 889 genes with significant fold changes, including downregulation of ECM components and modulation of PPAR signaling pathways. While the current study focuses on acute mechanistic dissection, these genomic signatures suggest that PM-induced macrophage activation initiates a broader transcriptional rewiring that extends beyond immediate insulin signaling nodes.

From a technical standpoint, the integration of real-ambient exposure, primary cell co-culture, pharmacological inhibition, and genetic knockdown creates a robust evidentiary hierarchy. The study avoids over-reliance on any single methodology, instead triangulating toward the same conclusion: macrophage NLRP3 inflammasome activation is an obligate step in PM-induced hepatic glucose metabolic disruption. The identification of lysosomal damage and cathepsin B release as upstream triggers adds mechanistic depth, while the demonstration that both NLRP3 inhibition and IL-1β neutralization prevent hepatocyte dysfunction highlights modifiable points within this signaling axis.

For researchers working at the intersection of environmental toxicology and immunometabolism, this work offers several actionable insights. First, it validates the use of real-ambient exposure systems over synthetic particle preparations when modeling urban pollution effects. Second, it establishes a reproducible co-culture framework for dissecting macrophage-hepatocyte crosstalk without confounding systemic variables. Third, it positions the NLRP3 inflammasome as a sensor that translates particulate internalization into metabolic signaling, expanding the known functional repertoire of this complex beyond classical pathogen response.

In summary, the study constructs a coherent mechanistic narrative in which ambient PM particles are internalized by hepatic macrophages, damage lysosomal compartments, trigger cathepsin B-dependent NLRP3 inflammasome assembly, drive IL-1β maturation and release, and subsequently impair insulin signaling and glucose homeostasis in neighboring hepatocytes. The functional attenuation achieved through NLRP3 knockdown, combined with the precise metabolic phenotyping enabled by standardized insulin challenge using AbMole reagents, provides compelling evidence that macrophage-intrinsic inflammasome activity is a critical node linking environmental exposure to hepatic metabolic dysfunction. Future investigations will likely extend this framework to examine whether other environmental toxicants converge on similar lysosome-inflammasome-metabolism axes, and whether tissue-specific modulation of this pathway can mitigate pollutant-associated metabolic disturbances.

AbMole Product Integration in This Study

Product: Recombinant Insulin (AbMole)

Application: In vivo insulin tolerance test (ITT) to quantify systemic insulin responsiveness in C57BL/6 mice following real-ambient particulate matter exposure and liver-specific Nlrp3 knockdown.

Experimental Details:

• Dose: 0.75 U/kg body weight
• Route: Intraperitoneal injection
• Fasting: 4 hours prior to challenge
• Monitoring: Blood glucose measured via tail-tip sampling at 0, 15, 30, 60, and 120 minutes post-injection
• Context: Conducted in both PM-exposed wild-type mice and AAV-shNLRP3 mice to assess whether hepatic NLRP3 silencing restores normal insulin-stimulated glucose clearance

Key Findings Enabled by AbMole Insulin:

• PM-exposed control animals displayed markedly blunted glucose clearance, indicating compromised peripheral insulin responsiveness
• Liver-specific Nlrp3 knockdown mice exhibited glucose decay kinetics comparable to filtered-air controls despite identical PM exposure
• The ITT data directly corroborated Western blot findings of restored IRS1-Akt phosphorylation in the knockdown group
• The standardized AbMole preparation ensured reproducible hormonal challenge across genotypes and exposure conditions, allowing quantitative comparison of insulin sensitivity